Abstract
The Sars-Cov2 pandemic highlighted the great potential of therapeutic strategies involving gene therapy, mainly due to the development of vectors capable of delivering mRNA and siRNA molecules. Among the various polymers used in non-viral gene therapy, biodegradable low molar mass amphipathic polymers have shown great potential and generated several patents focusing on the release of mRNA…